Rachel Burga
North Western University
H-index: 18
Asia-Bangladesh
Top articles of Rachel Burga
Administration of tumor infiltrating lymphocytes with membrane bound interleukin 15 to treat cancer
2022/5/5
Abstract LB072: Tumor-infiltrating lymphocytes (TIL) engineered with membrane-bound IL15 (cytoTIL15 cells) exhibit pharmacologically regulatable signal transduction in cis and …
Cancer Research
2024/4/5
Rachel Burga
H-Index: 13
Gauri Kulkarni
H-Index: 4
Tumor-infiltrating lymphocytes with membrane bound interleukin 15 and uses thereof
2024/4/4
Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof
2024/3/19
Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting
Cytotherapy
2023/6/1
Abstract LB096: IL15-engineered tumor infiltrating lymphocytes (cytoTIL15TM) exhibit activity against autologous tumor cells from multiple solid tumor indications …
Cancer Research
2023/4/14
Rachel Burga
H-Index: 13
Gauri Kulkarni
H-Index: 4
Abstract LB093: Engineering tumor infiltrating lymphocytes from sarcoma and colorectal tumors with membrane bound IL-15 for IL-2 independent expansion and enhanced cytotoxicity …
Cancer Research
2023/4/14
TIL engineered with membrane-bound IL15 (cytoTIL15™) are enriched for tumor-associated antigen reactivity and demonstrate pharmacologically tunable expansion and persistence …
2023
Rachel Burga
H-Index: 13
Gauri Kulkarni
H-Index: 4
Enhancers of innate and adaptive immunity combine with membrane bound IL15 to increase the efficacy of tumor infiltrating lymphocyte (TIL) therapy for tumors with …
J. Immunother. Cancer https://doi. org/10.1136/jitc-2022-sitc2022
2022/11/1
Digital spatial profiling and antigen-dependent phenotypic analysis of IL15-engineered tumor-infiltrating lymphocytes (cytoTIL15 TM therapy) in an allogeneic melanoma PDX model
2022/11/1
Abstract LB212: Allogeneic, IL-2-independent tumor-infiltrating lymphocytes expressing membrane-bound IL-15 (cytoTIL15࣪) eradicate tumors in a melanoma PDX model through …
Cancer Research
2022/6/15
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
Proceedings of the National Academy of Sciences
2022/1/4
166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo
2021/11/1
Rachel Burga
H-Index: 13
Kyle Pedro
H-Index: 4
1008P CytoTIL15: A novel TIL therapy for melanoma with superior potency and enhanced persistence without IL2 to improve safety & efficacy and expand patient eligibility
Annals of Oncology
2021/9/1
Rachel Burga
H-Index: 13
Kyle Pedro
H-Index: 4
An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model
Advanced nanobiomed research
2021/8
Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
Science Advances
2021/2/17
Modified natural killer cells and methods of using the same
2021/1/21
167 B-cell-based vaccination elicit potent immunity against glioblastoma
2020/11/1
Catalina Lee-Chang
H-Index: 13
Jason Miska
H-Index: 15
David Hou
H-Index: 3
Peng Zhang
H-Index: 2
Rachel Burga
H-Index: 13
EXTH-43. GENERATION OF A B-CELL-BASED VACCINE FOR THE TREATMENT OF GLIOBLASTOMA
Neuro-Oncology
2020/11
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
Journal of Experimental Medicine
2020/9/29
Co-Authors
